Edition:
United Kingdom

Conatus Pharmaceuticals Inc (CNAT.OQ)

CNAT.OQ on NASDAQ Stock Exchange Global Market

1.71USD
7 Dec 2018
Change (% chg)

$-0.23 (-11.86%)
Prev Close
$1.94
Open
$1.92
Day's High
$1.92
Day's Low
$1.52
Volume
403,798
Avg. Vol
122,059
52-wk High
$7.94
52-wk Low
$1.52

Chart for

About

Conatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active... (more)

Overall

Beta: 1.29
Market Cap(Mil.): $174.93
Shares Outstanding(Mil.): 30.00
Dividend: --
Yield (%): --

Financials

  CNAT.OQ Industry Sector
P/E (TTM): -- 92.25 33.63
EPS (TTM): -0.99 -- --
ROI: -53.65 0.28 15.02
ROE: -80.58 0.94 16.60

Earnings vs. Estimates